SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 72 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $54,000 | +1.9% | 98,513 | +0.6% | 0.00% | 0.0% |
| Q1 2016 | $53,000 | -56.9% | 97,913 | -28.4% | 0.00% | 0.0% |
| Q4 2015 | $123,000 | -2.4% | 136,833 | -12.0% | 0.00% | -50.0% |
| Q3 2015 | $126,000 | -77.7% | 155,433 | -17.1% | 0.00% | -75.0% |
| Q2 2015 | $564,000 | +121.2% | 187,428 | +79.8% | 0.01% | +100.0% |
| Q1 2015 | $255,000 | +140.6% | 104,219 | +150.4% | 0.00% | +100.0% |
| Q4 2014 | $106,000 | -58.6% | 41,626 | +6.1% | 0.00% | -50.0% |
| Q2 2014 | $256,000 | +8.0% | 39,229 | -21.6% | 0.00% | 0.0% |
| Q4 2013 | $237,000 | +149.5% | 50,023 | +173.5% | 0.00% | +100.0% |
| Q2 2013 | $95,000 | – | 18,288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,869,261 | $32,186,000 | 2.31% |
| GREAT POINT PARTNERS LLC | 193,567 | $1,279,000 | 0.67% |
| Visium Asset Management, LP | 4,526,750 | $29,922,000 | 0.48% |
| Healthcare Value Capital, LLC | 103,185 | $682,000 | 0.45% |
| ALYDAR PARTNERS LLC | 550,565 | $3,639,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 147,403 | $974,000 | 0.29% |
| HealthCor Management, L.P. | 690,000 | $4,561,000 | 0.27% |
| Sivik Global Healthcare LLC | 63,087 | $417,000 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,379,278 | $9,117,000 | 0.22% |
| Healthcare Value Capital, LLC | 50,000 | $331,000 | 0.22% |